Vito Amodio
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: January 04, 2026
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer.
Journal: Cancer research
Published: May 28, 2025
DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors.
Journal: British journal of cancer
Published: April 16, 2024
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models.
Journal: Cancer cell
Published: April 25, 2023
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 12, 2022
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.
Journal: Cancers
Published: April 14, 2021
T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models.
Journal: Cancer immunology research
Published: July 31, 2020
CD4 T Cell-Dependent Rejection of Beta-2 Microglobulin Null Mismatch Repair-Deficient Tumors.
Journal: Cancer discovery
Published: July 09, 2020
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer.
Journal: Cancer discovery
Published: February 17, 2020
Last Updated: 09/26/2026